Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Pharmacy staff profile

Dr Mohammed Salahudeen

PositionPostdoctoral Research Fellow
QualificationsBPharm PharmD MBA PhD
Research summaryRisks associated with polypharmacy and hyper-polypharmacy in older individuals using interRAI data
Memberships
  • Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)
  • Australasian Pharmaceutical Science Association (APSA)
  • International Society for Pharmacoepidemiology (ISPE)
Clinical
  • Geriatric pharmacotherapy
  • Pharmacoepidemiology
  • Quality use of medicines
  • Evidence-based medicine
  • Anticholinergic burden and adverse outcomes

Research

Advanced pharmacoepidemiological studies using interRAI data.

Publications

Salahudeen, M. S., & Nishtala, P. S. (2016). Examination and estimation of anticholinergic burden: Current trends and implications for future research. Drugs & Aging, 33(5), 305-313. doi: 10.1007/s40266-016-0362-5

Salahudeen, M. S., Hilmer, S. N., & Nishtala, P. S. (2015). Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. Journal of the American Geriatrics Society, 63(1), 85-90. doi: 10.1111/jgs.13206

Nishtala, P. S., Salahudeen, M. S., & Hilmer, S. N. (2016). Anticholinergics: Theoretical and clinical overview. Expert Opinion on Drug Safety, 15(6), 753-768. doi: 10.1517/14740338.2016.1165664

Salahudeen, M. S., Nishtala, P. S., & Duffull, S. B. (2015). The influence of patient characteristics on anticholinergic events in older people. Dementia & Geriatric Cognitive Disorders Extra, 5(3), 530-541. doi: 10.1159/000441718

Nishtala, P. S., & Salahudeen, M. S. (2015). Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005-2013. Gerontology, 61, 195-202. doi: 10.1159/000368191

Journal - Research Article

Salahudeen, M. S., & Nishtala, P. S. (2017). An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice. Saudi Pharmaceutical Journal, 25(2), 165-175. doi: 10.1016/j.jsps.2016.07.002

Nishtala, P. S., Salahudeen, M. S., & Hilmer, S. N. (2016). Anticholinergics: Theoretical and clinical overview. Expert Opinion on Drug Safety, 15(6), 753-768. doi: 10.1517/14740338.2016.1165664

Salahudeen, M. S., Chyou, T.-y., & Nishtala, P. S. (2016). Serum anticholinergic activity and cognitive and functional adverse outcomes in older people: A systematic review and meta-analysis of the literature. PLoS ONE, 11(3), e0151084. doi: 10.1371/journal.pone.0151084

Salahudeen, M. S., & Nishtala, P. S. (2016). Examination and estimation of anticholinergic burden: Current trends and implications for future research. Drugs & Aging, 33(5), 305-313. doi: 10.1007/s40266-016-0362-5

Nishtala, P. S., Castelino, R. L., Peterson, G. M., Hannan, P. J., & Salahudeen, M. S. (2016). Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: Assessment of stroke and bleeding risk. Journal of Clinical Pharmacy & Therapeutics, 41(3), 279-284. doi: 10.1111/jcpt.12385

Nishtala, P. S., & Salahudeen, M. S. (2016). Temporal trends in the use of antidiabetic medicines: A nationwide 9-year study in older people living in New Zealand. Therapeutic Advances in Drug Safety. doi: 10.1177/2042098616660948

Nishtala, P. S., & Salahudeen, M. S. (2015). Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005-2013. Gerontology, 61, 195-202. doi: 10.1159/000368191

Salahudeen, M. S., Hilmer, S. N., & Nishtala, P. S. (2015). Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. Journal of the American Geriatrics Society, 63(1), 85-90. doi: 10.1111/jgs.13206

Salahudeen, M. S., Duffull, S. B., & Nishtala, P. S. (2015). Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: A systematic review. BMC Geriatrics, 15, 31. doi: 10.1186/s12877-015-0029-9

Salahudeen, M. S., Nishtala, P. S., & Duffull, S. B. (2015). The influence of patient characteristics on anticholinergic events in older people. Dementia & Geriatric Cognitive Disorders Extra, 5(3), 530-541. doi: 10.1159/000441718

Salahudeen, M. S., Duffull, S. B., & Nishtala, P. S. (2014). Impact of anticholinergic discontinuation on cognitive outcomes in older people: A systematic review. Drugs & Aging, 31(3), 185-192. doi: 10.1007/s40266-014-0158-4

Salahudeen, M. S., Koshy, A. M., & Sen, S. (2013). A study of the factors affecting time to onset of lactogenesis-II after parturition. Journal of Pharmacy Research, 6(1), 68-72. doi: 10.1016/j.jopr.2012.11.015

Kulkarni, V., Bora, S. S., Sirisha, S., Saji, M., & Sundaran, S. (2013). A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital. Therapeutic Advances in Drug Safety, 4(4), 474-476. doi: 10.1177/2042098613490009

^ Top of page

Journal - Research Other

Nishtala, P. S., Ndukwe, H. C., Chyou, T.-y., Salahudeen, M. S., & Narayan, S. W. (2017). An overview of pharmacoepidemiology in New Zealand: Medical databases, registries and research achievements. New Zealand Medical Journal, 130(1449), 52-61. Retrieved from https://www.nzma.org.nz/journal

Nishtala, P. S., & Salahudeen, M. S. (2016). Cognitive adverse effects and brain deterioration associated with use of anticholinergic activity medicines in older adults. Evidence-Based Medicine, 21(6), 235. doi: 10.1136/ebmed-2016-110555

Salahudeen, M. S., & Nishtala, P. S. (2015). Credentials for a PharmD graduate: The voyage never ends. SAGE Open Medicine, 3, 2050312115584228. doi: 10.1177/2050312115584228

More publications...